...Visualise the World...


National Eye Institute

23/09/2008 14:16

Promising Results in Phase 1 Gene Therapy Trial for Blinding Disease

Three young adults with an inherited form of blindness showed evidence of improved day and night vision following a specialized gene transfer procedure in a phase 1 clinical trial funded by the National Eye Institute (NEI), part of the National Institutes of Health. In addition no adverse effects from the therapy were reported.

Read more at: https://www.nei.nih.gov

 

—————

Back



mda06dr